Mangoceuticals, Inc. Common Stock (MGRX) — Working Capital to Net Assets Ratio
Mangoceuticals, Inc. Common Stock (MGRX) has a Working Capital to Net Assets ratio of -1.3% as of September 2025. Working capital of $-206.05K (current assets of $598.22K minus current liabilities of $804.27K) is measured against net assets of $15.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Mangoceuticals, Inc. Common Stock leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Mangoceuticals, Inc. Common Stock Working Capital to Net Assets (2021–2024)
This chart shows how Mangoceuticals, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at -1.3%, reflecting working capital of $-206.05K against net assets of $15.73 Million USD. See defensive interval ratio of Mangoceuticals, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Mangoceuticals, Inc. Common Stock (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Mangoceuticals, Inc. Common Stock from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Mangoceuticals, Inc. Common Stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -9.7% | $-1.35 Million | $13.95 Million | $75.59K | $1.43 Million | ▼ -88.1 pp |
| 2023 | 78.4% | $607.38K | $774.75K | $818.46K | $211.08K | ▲ +7.7 pp |
| 2022 | 70.7% | $434.03K | $614.03K | $694.61K | $260.58K | ▼ -29.3 pp |
| 2021 | 100.0% | $-16.72K | $-16.72K | $22.55K | $39.27K | — |